BSX
BOSTON SCIENTIFIC CORP
NYSE: BSX · Marlborough, MA · Healthcare
$45.69-0.32 (-0.70%)Closed
Market Cap$63.93B
Cash$539.0Mmost recent
Runwayprofitable
P/E (TTM)23.6EPS $1.94
52-Wk Range$41.58 – $104.98
Avg Volume16.7M3-month
Price & Trading Activity
Daily close with catalyst overlays and trading volume
$45.69-46.3%
Pipeline
Drug candidates sponsored by BOSTON SCIENTIFIC · ClinicalTrials.gov
| Phase | Drug / Candidate | Indications | Status | Next Completion | Trials | |
|---|---|---|---|---|---|---|
| Phase 4 | Unnamed | Carotid Stenosis | Terminated | 2009-07past | 1 | |
| Phase 4 | Unnamed | Neuropathic Pain+1 more | Completed | 2009-08past | 1 | |
| Phase 4 | Unnamed | Carotid Artery Disease | Completed | 2010-10past | 1 | |
| Phase 4 | Unnamed | Peripheral Arterial Disease | Completed | 2012-03past | 1 | |
| Phase 4 | Recombinant tissue plasminogen activator | Pulmonary Embolism and Thrombosis | Completed | 2019-04-30past | 1 | |
| Phase 4 | Unnamed | Heart Failure | Completed | — | 1 | |
| Phase 3 | Unnamed | Heart Failure+1 more | Completed | 2004-10past | 1 | |
| Phase 2 | Unnamed | Coronary Stenosis | Completed | 2004-12past | 1 | |
| Phase 3 | Unnamed | Bradycardia | Completed | 2005-05past | 1 | |
| Phase 3 | Unnamed | Coronary Artery Disease | Completed | 2006-12past | 1 | |
| Phase 3 | Unnamed | Cholestasis, Extrahepatic | Completed | 2008-05past | 1 | |
| Phase 3 | Unnamed | Coronary Artery Disease | Completed | 2009-06past | 1 | |
| Phase 3 | Unfractionated heparin | Submassive Pulmonary Embolism | Completed | 2013-04past | 1 | |
| Phase 3 | Unnamed | Critical Limb Ischemia | Completed | 2022-04-21past | 1 | |
| Phase 2 | Unnamed | Congestive Heart Failure | Completed | — | 1 | |
| Phase 2 | Unnamed | Congestive Heart Failure | Completed | — | 1 | |
| Phase 3 | Unnamed | Atrial Flutter | Completed | — | 1 | |
| Phase 2 | OncoGel (Paclitaxel gel) | Esophageal Cancer+2 more | Terminated | 2010-11past | 1 | |
| Phase 2 | Unnamed | Abdominal Aortic Aneurysm | Withdrawn | — | 1 | |
| Phase 1 | Unnamed | Pain+1 more | Terminated | 2015-01past | 1 | |
| Early Phase 1 | BTG-002814 | Carcinoma, Hepatocellular+1 more | Completed | 2019-08-03past | 1 | |
| N/A | Unnamed | Heart Failure | Completed | 2007-03past | 1 | |
| N/A | Unnamed | Ventricular Tachycardia+1 more | Completed | 2007-08past | 1 | |
| N/A | Unnamed | Intractable Neuropathic Pain+3 more | Terminated | 2008-05past | 1 | |
| N/A | Unnamed | Arrhythmia | Completed | 2008-10past | 1 | |
| N/A | Unnamed | ACC/AHA/NASPE Class 1, IIa or IIb Indications | Completed | 2009-03past | 1 | |
| N/A | Unnamed | Tachycardia+1 more | Completed | 2009-06past | 1 | |
| N/A | Unnamed | Heart Failure | Terminated | 2009-10past | 1 | |
| N/A | Unnamed | Carotid Artery Disease+2 more | Completed | 2011-06past | 1 | |
| N/A | Unnamed | Tachycardia, Ventricular | Completed | 2011-10past | 1 | |
| N/A | Unnamed | First Degree AV Block | Terminated | 2012-01past | 1 | |
| N/A | Unnamed | Coronary Heart Disease | Completed | 2012-06past | 1 | |
| N/A | Unnamed | Heart Failure | Completed | 2012-08past | 1 | |
| N/A | Unnamed | Stress Urinary Incontinence | Completed | 2012-12past | 1 | |
| N/A | Unnamed | Coronary Heart Disease | Completed | 2013-03past | 1 | |
| N/A | Unnamed | Peripheral Vascular Disease+2 more | Completed | 2013-07past | 1 | |
| N/A | Unnamed | Hypertension | Completed | 2013-11past | 1 | |
| N/A | Unnamed | Uterine Fibroids | Terminated | 2013-12past | 1 | |
| N/A | Unnamed | Heart Failure+1 more | Active, not recruiting | 2014-05past | 1 | |
| N/A | Unnamed | Transcatheter Aortic Valve Replacement | Completed | 2014-05-30past | 1 | |
| N/A | Unnamed | Benign Prostatic Hyperplasia | Completed | 2014-10past | 1 | |
| N/A | Unnamed | Obesity | Completed | 2015-02past | 1 | |
| N/A | Unnamed | Refractory Benign Esophageal Strictures Caused by Caustic Ingestion | Completed | 2015-11past | 1 | |
| N/A | Unnamed | Emphysema | Terminated | 2015-12past | 1 | |
| N/A | Unnamed | Arhythmia+4 more | Completed | 2016-03-16past | 1 | |
| N/A | Unnamed | Biliary Strictures | Completed | 2016-03-31past | 1 | |
| N/A | Unnamed | Bradycardia | Completed | 2016-06past | 1 | |
| N/A | Unnamed | Pulmonary Embolism+1 more | Completed | 2016-08past | 1 | |
| N/A | Unnamed | Biliary Stricture+3 more | Completed | 2016-09past | 1 | |
| N/A | Unnamed | Aortic Stenosis | Completed | 2016-10-06past | 1 | |
| N/A | Unnamed | Colorectal Carcinoma | Completed | 2016-12past | 1 | |
| N/A | Unnamed | Chronic Pain | Completed | 2017-02-21past | 1 | |
| N/A | Unnamed | Aortic Valve Stenosis | Completed | 2017-04-04past | 1 | |
| N/A | Unnamed | Barrett's Esophagus | Completed | 2017-05past | 1 | |
| N/A | Unnamed | Chronic Venous Disorder+2 more | Completed | 2017-12-05past | 1 | |
| N/A | Unnamed | Pancreatic Cancer | Completed | 2018-02-21past | 1 | |
| N/A | Unnamed | Atrial Fibrillation+1 more | Terminated | 2019-01-10past | 1 | |
| N/A | Unnamed | Arrhythmias, Cardiac | Completed | 2019-05-23past | 1 | |
| N/A | Acetylsalicylic Acid | Chronic Total Occlusion+3 more | Withdrawn | 2019-12-01past | 1 | |
| N/A | Unnamed | Cardiovascular Diseases | Completed | 2020-03-11past | 1 | |
| N/A | Unnamed | Pulmonary Embolism and Thrombosis | Completed | 2020-06-30past | 1 | |
| N/A | Unnamed | Biliary Stricture | Completed | 2020-09-21past | 1 | |
| N/A | Unnamed | Left Ventricular Dysfunction | Completed | 2020-11-19past | 1 | |
| N/A | Unnamed | Kidney Neoplasms | Terminated | 2020-11-24past | 1 | |
| N/A | Unnamed | Stenoses, Aortic Valve | Withdrawn | 2020-11-30past | 1 | |
| N/A | Unnamed | Heart Failure+2 more | Completed | 2020-12-01past | 1 | |
| N/A | Unnamed | Coronary Artery Disease | Completed | 2020-12-28past | 1 | |
| N/A | Unnamed | Bradycardia | Completed | 2021-03-01past | 1 | |
| N/A | Unnamed | Benign Prostatic Hyperplasia (BPH) | Completed | 2021-03-30past | 1 | |
| N/A | Unnamed | Implantable Cardioverter Defibrillators+1 more | Completed | 2021-08past | 1 | |
| N/A | Unnamed | Chronic Pain | Completed | 2021-10-01past | 1 | |
| N/A | Unnamed | Heart Failure+5 more | Completed | 2021-10-29past | 1 | |
| N/A | Unnamed | Cholecystitis, Acute | Completed | 2021-12-02past | 1 | |
| N/A | Unnamed | Paroxysmal Atrial Fibrillation | Completed | 2021-12-21past | 1 | |
| N/A | Unnamed | Unresectable Hepatocellular Carcinoma | Completed | 2022-04-30past | 1 | |
| N/A | Unnamed | Paroxysmal Atrial Fibrillation | Completed | 2022-07-21past | 1 | |
| N/A | Unnamed | Atherosclerosis+3 more | Completed | 2022-08-19past | 1 | |
| N/A | Unnamed | Paroxysmal Atrial Fibrillation | Completed | 2022-11-10past | 1 | |
| N/A | Unnamed | Endoscopic Retrograde Cholangiopancreatography | Completed | 2022-11-23past | 1 | |
| N/A | Unnamed | Atrial Tachycardia (Including Atrial Flutter) Post Atrial Fibrillation Ablation or Cardiac Surgery | Withdrawn | 2022-12past | 1 | |
| N/A | Unnamed | Lumbar Spinal Stenosis | Completed | 2023-03-20past | 1 | |
| N/A | Unnamed | Localized T1-T2 Prostate Cancer | Completed | 2023-06-12past | 1 | |
| N/A | Unnamed | Paroxysmal Atrial Fibrillation | Completed | 2023-08-21past | 1 | |
| N/A | Unnamed | Atrial Fibrillation+2 more | Completed | 2024-07-15past | 1 | |
| N/A | Unnamed | Non-valvular Atrial Fibrillation (AF) | Completed | 2024-10-14past | 1 | |
| N/A | Unnamed | Respiration Rate Detection | Completed | 2026-08-24past | 1 | |
| N/A | Unnamed | Persistent Atrial Fibrillation | Active, not recruiting | 2027-04 | 1 | |
| N/A | Unnamed | Atrial Fibrillation+2 more | Active, not recruiting | 2027-04-01 | 1 | |
| N/A | Unnamed | Atrial Arrhythmia+1 more | Recruiting | 2027-06-30 | 1 | |
| N/A | Unnamed | Persistent Atrial Fibrillation | Recruiting | 2027-12-30 | 1 | |
| N/A | Unnamed | Paroxysmal AF | Active, not recruiting | 2027-12-31 | 1 | |
| N/A | Unnamed | Prostate+1 more | Active, not recruiting | 2028-01 | 1 | |
| N/A | Unnamed | Coronary Arterial Disease (CAD)+1 more | Recruiting | 2028-03 | 1 | |
| N/A | Unnamed | Motor Epilepsy | Not yet recruiting | 2028-05-31 | 1 | |
| N/A | Unnamed | Weight Loss | Recruiting | 2028-06-30 | 1 | |
| N/A | Unnamed | Atrial Fibrillation (AF)+5 more | Recruiting | 2028-12 | 1 | |
| N/A | Unnamed | Heart Failure - NYHA II - IV | Recruiting | 2029-11 | 1 | |
| N/A | Unnamed | Chronic Low-back Pain+1 more | Recruiting | 2034-07 | 1 | |
| N/A | Unnamed | Heart Failure | Completed | — | 1 | |
| N/A | Unnamed | Heart Failure | Terminated | — | 1 |
Valuation
Risk-adjusted NPV
Loading pipeline…
Peer comparison
Cohort check
No peer cohort defined for BSX. Cohorts currently cover gene editing, mRNA, rare-disease gene therapy, and large-cap biotech — more coming soon.